Loading...
Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Lynda Diane Roman, MD

    TitleAssociate Professor of Obstetrics & Gynecology
    SchoolKeck School of Medicine of USC
    DepartmentObstetrics & Gynecology
    AddressIRD 528
    Off Campus
    Los Angeles California 90089-9300
    Phone+1 323 409 3405
    vCardDownload vCard
      Other Positions
      TitleDivision Chief, Gynecologic Oncology

      TitleDirector, Gynecology Oncology Fellowship


      Collapse Overview 
      Collapse Overview
      Dr. Roman completed her fellowship in gynecologic oncology at the MD Anderson Cancer Center in Houston, Texas in 1991. Presently, she serves as Director of the Division of Gynecologic Oncology at the University of Southern California, as well as the Director of Research and the Fellowship Program Director. Also, Dr. Roman is the co-director of the Lynne Cohen Preventive Cancer Care Clinic at the USC/Norris Cancer Center. she has recently been appointed to the governing council of the Society of Gynecologic Oncologists.


      Collapse Biography 
      Collapse Clinical Trials

      Collapse ORNG Applications 
      Collapse Websites

      Collapse Bibliographic 
      Collapse Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Matsuo K, Wong KK, Fotopoulou C, Blake EA, Robertson SE, Pejovic T, Frimer M, Pardeshi V, Hu W, Choi JS, Sun CC, Richmond AM, Marcus JZ, Hilliard MAM, Mostofizadeh S, Mhawech-Fauceglia P, Abdulfatah E, Post MD, Shahzad MMK, Karabakhtsian RG, Ali-Fehmi R, Gabra H, Roman L, Sood AK, Gershenson DM. Impact of lympho-vascular space invasion on tumor characteristics and survival outcome of women with low-grade serous ovarian carcinoma. J Surg Oncol. 2017 Aug 08. PMID: 28787528.
        View in: PubMed
      2. Matsuo K, Machida H, Stone RL, Soliman PT, Thaker PH, Roman L, Wright JD. Risk of Subsequent Ovarian Cancer After Ovarian Conservation in Young Women With Stage I Endometrioid Endometrial Cancer. Obstet Gynecol. 2017 Jul 07. PMID: 28697110.
        View in: PubMed
      3. Matsuo K, Machida H, Blake EA, Takiuchi T, Mikami M, Roman L. Significance of uterine corpus tumor invasion in early-stage cervical cancer. Eur J Surg Oncol. 2017 Feb 03. PMID: 28215507.
        View in: PubMed
      4. Matsuo K, Machida H, Takiuchi T, Grubbs BH, Roman L, Sood AK, Gershenson DM. Role of hysterectomy and lymphadenectomy in the management of early-stage borderline ovarian tumors. Gynecol Oncol. 2017 Jan 26. PMID: 28131526.
        View in: PubMed
      5. Matsuo K, Machida H, Ragab OM, Takiuchi T, Pham HQ, Roman L. Extent of pelvic lymphadenectomy and use of adjuvant vaginal brachytherapy for early-stage endometrial cancer. Gynecol Oncol. 2016 Dec 22. PMID: 28017306.
        View in: PubMed
      6. Matsuo K, Ross MS, Bush SH, Yunokawa M, Blake EA, Takano T, Ueda Y, Baba T, Satoh S, Shida M, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Takeuchi S, Nishimura M, Iwasaki K, Yanai S, Klobocista MM, Johnson MS, Machida H, Hasegawa K, Miyake TM, Nagano T, Pejovic T, Shahzad MM, Im DD, Omatsu K, Ueland FR, Kelley JL, Roman L. Tumor characteristics and survival outcomes of women with tamoxifen-related uterine carcinosarcoma. Gynecol Oncol. 2016 Dec 05. PMID: 27931750.
        View in: PubMed
      7. Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman L, Wright JD. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Cervical Cancer. Obstet Gynecol. 2016 Dec 02. PMID: 27926642.
        View in: PubMed
      8. Tierney KE, Ji L, Dralla SS, Yoo E, Yessaian A, Pham HQ, Roman L, Sposto R, Mhawech-Fauceglia P, Lin YG. Endoplasmic reticulum stress in complex atypical hyperplasia as a possible predictor of occult carcinoma and progestin response. Gynecol Oncol. 2016 Oct 19. PMID: 27771165.
        View in: PubMed
      9. Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, Doherty JA, Schildkraut JM, Kjaer SK, Ness RB, Menon U, Berchuck A, Mukherjee B, Roman L, Pharoah PD, Chenevix-Trench G, Olson S, Hogdall E, Wu AH, Pike MC, Stram DO, Pearce CL. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. Int J Cancer. 2016 Dec 15; 139(12):2646-2654. PMID: 27420401.
        View in: PubMed
      10. Matsuo K, Machida H, Shoupe D, Melamed A, Muderspach LI, Roman L, Wright JD. Ovarian Conservation and Overall Survival in Young Women With Early-Stage Low-Grade Endometrial Cancer. Obstet Gynecol. 2016 Sep 5. PMID: 27607873.
        View in: PubMed
      11. Matsuo K, Moeini A, Machida H, Fullerton ME, Shabalova A, Brunette LL, Roman L. Significance of venous thromboembolism in women with cervical cancer. Gynecol Oncol. 2016 Jun 24. PMID: 27350404.
        View in: PubMed
      12. Matsuo K, Cahoon SS, Yoshihara K, Shida M, Kakuda M, Adachi S, Moeini A, Machida H, Garcia-Sayre J, Ueda Y, Enomoto T, Mikami M, Roman L, Sood AK. Association of Low-Dose Aspirin and Survival of Women With Endometrial Cancer. Obstet Gynecol. 2016 Jun 6. PMID: 27275802.
        View in: PubMed
      13. Lee AW, Ness RB, Roman L, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, Moysich KB, Berchuck A, Rossing MA, Jensen A, Wicklund KG, Cushing-Haugen KL, Hogdall E, Rudolph A, Thompson PJ, Wilkens LR, Kjaer SK, Carney ME, Stram DO, Ramus SJ, Wu AH, Pike MC, Pearce CL. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstet Gynecol. 2016 May; 127(5):828-36. PMID: 27054934.
        View in: PubMed
      14. Matsuo K, Takazawa Y, Ross MS, Elishaev E, Podzielinski I, Yunokawa M, Sheridan TB, Bush SH, Klobocista MM, Blake EA, Takano T, Matsuzaki S, Baba T, Satoh S, Shida M, Nishikawa T, Ikeda Y, Adachi S, Yokoyama T, Takekuma M, Fujiwara K, Hazama Y, Kadogami D, Moffitt MN, Takeuchi S, Nishimura M, Iwasaki K, Ushioda N, Johnson MS, Yoshida M, Hakam A, Li SW, Richmond AM, Machida H, Mhawech-Fauceglia P, Ueda Y, Yoshino K, Yamaguchi K, Oishi T, Kajiwara H, Hasegawa K, Yasuda M, Kawana K, Suda K, Miyake TM, Moriya T, Yuba Y, Morgan T, Fukagawa T, Wakatsuki A, Sugiyama T, Pejovic T, Nagano T, Shimoya K, Andoh M, Shiki Y, Enomoto T, Sasaki T, Fujiwara K, Mikami M, Shimada M, Konishi I, Kimura T, Post MD, Shahzad MM, Im DD, Yoshida H, Omatsu K, Ueland FR, Kelley JL, Karabakhtsian RG, Roman L. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma. Ann Oncol. 2016 Apr 6. PMID: 27052653.
        View in: PubMed
      15. Matsuo K, Gualtieri MR, Cahoon SS, Toboni MD, Machida H, Moeini A, Hasegawa K, Shoupe D, Roman L. Contributing factors for menopausal symptoms after surgical staging for endometrial cancer. Menopause. 2015 Dec 29. PMID: 26757269.
        View in: PubMed
      16. Matsuo K, Jung CE, Hom MS, Gualtieri MR, Randazzo SC, Kanao H, Yessaian AA, Roman L. Predictive Factor of Conversion to Laparotomy in Minimally Invasive Surgical Staging for Endometrial Cancer. Int J Gynecol Cancer. 2015 Nov 14. PMID: 26569058.
        View in: PubMed
      17. Matsuo K, Moeini A, Machida H, Scannell CA, Casabar JK, Kakuda M, Adachi S, Garcia-Sayre J, Ueda Y, Roman L. Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis. Ann Surg Oncol. 2015 Nov 5. PMID: 26542589.
        View in: PubMed
      18. Machida H, Casey JP, Garcia-Sayre J, Jung CE, Casabar JK, Moeini A, Kato K, Roman L, Matsuo K. Timing of intra-uterine manipulator insertion during minimally invasive surgical staging and results of pelvic cytology in endometrial cancer. J Minim Invasive Gynecol. 2015 Oct 13. PMID: 26475765.
        View in: PubMed
      19. Matsuo K, Garcia-Sayre J, Medeiros F, Casabar JK, Machida H, Moeini A, Roman L. Impact of depth and extent of lymphovascular space invasion on lymph node metastasis and recurrence patterns in endometrial cancer. J Surg Oncol. 2015 Sep 22. PMID: 26391212.
        View in: PubMed
      20. Da Silva DM, Woodham AW, Skeate JG, Rijkee LK, Taylor JR, Brand HE, Muderspach LI, Roman L, Yessaian AA, Pham HQ, Matsuo K, Lin YG, McKee GM, Salazar AM, Martin Kast W. Langerhans cells from women with cervical precancerous lesions become functionally responsive against human papillomavirus after activation with stabilized poly-I:C. Clin Immunol. 2015 Sep 7. PMID: 26360252.
        View in: PubMed
      21. Matsuo K, Hasegawa K, Yoshino K, Murakami R, Hisamatsu T, Stone RL, Previs RA, Hansen JM, Ikeda Y, Miyara A, Hiramatsu K, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Roman L, Gabra H, Fotopoulou C, Sood AK. Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma. Eur J Cancer. 2015 Jul 31. PMID: 26238017.
        View in: PubMed
      22. Matsuo K, Ramzan AA, Gualtieri MR, Mhawech-Fauceglia P, Machida H, Moeini A, Dancz CE, Ueda Y, Roman L. Prediction of concurrent endometrial carcinoma in women with endometrial hyperplasia. Gynecol Oncol. 2015 Jul 31. PMID: 26238457.
        View in: PubMed
      23. Machida H, Moeini A, Roman L, Matsuo K. Effects of imiquimod on vulvar Paget's disease: a systematic review of literature. Gynecol Oncol. 2015 Jul 17. PMID: 26193428.
        View in: PubMed
      24. Matsuo K, Gualtieri MR, Cahoon SS, Jung CE, Paulson RJ, Shoupe D, Muderspach LI, Wakatsuki A, Wright JD, Roman L. Surgical menopause and increased risk of nonalcoholic fatty liver disease in endometrial cancer. Menopause. 2015 Jul 13. PMID: 26173075.
        View in: PubMed
      25. Lawrenson K, Pakzamir E, Liu B, Lee JM, Delgado MK, Duncan K, Gayther SA, Liu S, Roman L, Mhawech-Fauceglia P. Molecular Analysis of Mixed Endometrioid and Serous Adenocarcinoma of the Endometrium. PLoS One. 2015; 10(7):e0130909. PMID: 26132201.
        View in: PubMed
      26. Matsuo K, Tierney KE, Schneider DM, Mhawech-Fauceglia P, Roman L, Gershenson DM. Characteristics of ovarian tumors of low malignant potential in BRCA mutation carriers: A case series. Gynecol Oncol Rep. 2015 Aug; 13:36-9. PMID: 26425718.
        View in: PubMed
      27. Matsuo K, Opper NR, Roman L. In Reply. Obstet Gynecol. 2015 Jun; 125(6):1498. PMID: 26000531.
        View in: PubMed
      28. Matsuo K, Hom MS, Moeini A, Machida H, Takeshima N, Roman L, Sood AK. Significance of monocyte counts on tumor characteristics and survival outcome of women with endometrial cancer. Gynecol Oncol. 2015 May 23. PMID: 26013698.
        View in: PubMed
      29. Ravaud A, Barrios CH, Alekseev B, Tay MH, Agarwala SS, Yalcin S, Lin CC, Roman L, Shkolnik M, Anak O, Gogov S, Pelov D, Louveau AL, Melichar B. RECORD-2: phase II randomized study of everolimus and bevacizumab versus interferon a-2a and bevacizumab as first-line therapy in patients with metastatic renal cell carcinoma. Ann Oncol. 2015 Jul; 26(7):1378-84. PMID: 25851632.
        View in: PubMed
      30. Matsuo K, Opper NR, Ciccone MA, Garcia J, Tierney KE, Baba T, Muderspach LI, Roman L. Time interval between endometrial biopsy and surgical staging for type I endometrial cancer: association between tumor characteristics and survival outcome. Obstet Gynecol. 2015 Feb; 125(2):424-33. PMID: 25569000.
        View in: PubMed
      31. Wu E, Rogers A, Ji L, Sposto R, Church T, Roman L, Tripathy D, Lin YG. Escalation of oncologic services at the end of life among patients with gynecologic cancer at an urban, public hospital. J Oncol Pract. 2015 Mar; 11(2):e163-9. PMID: 25604595.
        View in: PubMed
      32. Shostka KG, Pavlenko AN, Fedchenko AV, Fokina AV, Sakharov AA, Roman L. [OUTCOME OF PELVIC EXENTERATION FOR LOCALLY ADVANCED CANCER OF THE PELVIC ORGANS]. Vopr Onkol. 2015; 61(3):448-51. PMID: 26242160.
        View in: PubMed
      33. Matsuo K, Yoshino K, Hasegawa K, Murakami R, Ikeda Y, Adachi S, Hiramatsu K, Yokoyama T, Nishimura M, Sheridan TB, Enomoto T, Fujiwara K, Matsumura N, Konishi I, Fotopoulou C, Roman L, Sood AK. Survival outcome of stage I ovarian clear cell carcinoma with lympho-vascular space invasion. Gynecol Oncol. 2015 Feb; 136(2):198-204. PMID: 25497604.
        View in: PubMed
      34. Piatek CI, Raja GL, Ji L, Gitlitz BJ, Dorff TB, Quinn DI, Hu J, El-Khoueiry AB, Pham HQ, Roman L, Garcia AA. Phase I clinical trial of temsirolimus and vinorelbine in advanced solid tumors. Cancer Chemother Pharmacol. 2014 Dec; 74(6):1227-34. PMID: 25374407.
        View in: PubMed
      35. Matsuo K, Cahoon SS, Gualtieri M, Scannell CA, Jung CE, Takano T, Paulson RJ, Muderspach LI, Roman L. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer. Ann Surg Oncol. 2014 Dec; 21(13):4246-55. PMID: 25001096.
        View in: PubMed
      36. Matsuo K, Yoshino K, Hiramatsu K, Banzai C, Hasegawa K, Yasuda M, Nishimura M, Sheridan TB, Ikeda Y, Shiki Y, Mabuchi S, Enomoto T, Kimura T, Fujiwara K, Roman L, Sood AK. Effect of lymphovascular space invasion on survival of stage I epithelial ovarian cancer. Obstet Gynecol. 2014 May; 123(5):957-65. PMID: 24785846.
        View in: PubMed
      37. Matsuo K, Sheridan TB, Mabuchi S, Yoshino K, Hasegawa K, Studeman KD, Im DD, Rosenshein NB, Roman L, Sood AK. Estrogen receptor expression and increased risk of lymphovascular space invasion in high-grade serous ovarian carcinoma. Gynecol Oncol. 2014 Jun; 133(3):473-9. PMID: 24674832.
        View in: PubMed
      38. Lentz SE, Tierney KE, Weaver FA, Roman L. Abdominal Aortic Resection and Y-Graft Placement to Achieve Complete Cytoreduction in Stage IIIc Ovarian Carcinoma. Obstet Gynecol. 2014 Feb; 123(2 Pt 2):486-8. PMID: 24413236.
        View in: PubMed
      39. Herzog TJ, Monk BJ, Rose PG, Braly P, Hines JF, Bell MC, Wenham RM, Secord AA, Roman L, Einstein MH, Drake RD, Childs BH. A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube. Gynecol Oncol. 2014 Mar; 132(3):517-25. PMID: 24476788.
        View in: PubMed
      40. Baselga J, Manikhas A, Cortés J, Llombart A, Roman L, Semiglazov VF, Byakhov M, Lokanatha D, Forenza S, Goldfarb RH, Matera J, Azarnia N, Hudis CA, Rozencweig M. Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer. Ann Oncol. 2014 Mar; 25(3):592-8. PMID: 24401928.
        View in: PubMed
      41. Shostka KG, Pavlenko AN, Fokina AV, Kashina NO, Roman L. [Immediate and long-term results of treatment after pelvic exenteration for locally advanced cervical cancer]. Vopr Onkol. 2014; 60(3):319-22. PMID: 25033683.
        View in: PubMed
      42. Karpenko AV, Sibgatullin RR, Belova EN, Boiko AA, Zolotykh VG, Roman L. [Results of surgical treatment of oral cavity cancer T1-2N0M0]. Vestn Khir Im I I Grek. 2014; 173(2):52-6. PMID: 25055535.
        View in: PubMed
      43. Peeters M, Price TJ, Cervantes A, Sobrero AF, Ducreux M, Hotko Y, André T, Chan E, Lordick F, Punt CJ, Strickland AH, Wilson G, Ciuleanu TE, Roman L, Van Cutsem E, Tian Y, Sidhu R. Final results from a randomized phase 3 study of FOLFIRI {+/-} panitumumab for second-line treatment of metastatic colorectal cancer. Ann Oncol. 2014 Jan; 25(1):107-16. PMID: 24356622.
        View in: PubMed
      44. Tierney KE, Lin PS, Amezcua C, Matsuo K, Ye W, Felix JC, Roman L. Cervical conization of adenocarcinoma in situ: a predicting model of residual disease. Am J Obstet Gynecol. 2014 Apr; 210(4):366.e1-5. PMID: 24370689.
        View in: PubMed
      45. Chandavarkar U, Kuperman JM, Muderspach LI, Opper N, Felix JC, Roman L. Endometrial echo complex thickness in postmenopausal endometrial cancer. Gynecol Oncol. 2013 Oct; 131(1):109-12. PMID: 23917081.
        View in: PubMed
      46. Cohn DE, Leitao M, Levenback C, Berkowitz R, Roman L, Lucci J, Kim S, Lancaster J, Odunsi K, Wakabayashi M, Goff BA. Reporting of quality measures in gynecologic oncology programs at Prospective Payment System (PPS)-Exempt Cancer Hospitals: an early glimpse into a challenging initiative. Gynecol Oncol. 2013 Sep; 130(3):403-6. PMID: 23718934.
        View in: PubMed
      47. Wolpin BM, O'Reilly EM, Ko YJ, Blaszkowsky LS, Rarick M, Rocha-Lima CM, Ritch P, Chan E, Spratlin J, Macarulla T, McWhirter E, Pezet D, Lichinitser M, Roman L, Hartford A, Morrison K, Jackson L, Vincent M, Reyno L, Hidalgo M. Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer. Ann Oncol. 2013 Jul; 24(7):1792-801. PMID: 23448807.
        View in: PubMed
      48. Matsuo K, Yessaian AA, Lin YG, Pham HQ, Muderspach LI, Liebman HA, Morrow CP, Roman L. Predictive model of venous thromboembolism in endometrial cancer. Gynecol Oncol. 2013 Mar; 128(3):544-51. PMID: 23262205.
        View in: PubMed
      49. Matsuo K, Sheridan TB, Yoshino K, Miyake T, Hew KE, Im DD, Rosenshein NB, Mabuchi S, Enomoto T, Kimura T, Sood AK, Roman L. Significance of lymphovascular space invasion in epithelial ovarian cancer. Cancer Med. 2012 Oct; 1(2):156-64. PMID: 23342265.
        View in: PubMed
      50. Matsuo K, Fleischman F, Ghattas CS, Gabrielyan AS, Ballard CA, Roman L, Morrow CP. Successful extraction of cardiac-extending intravenous leiomyomatosis through gonadal vein. Fertil Steril. 2012 Nov; 98(5):1341-1345.e1. PMID: 22902061.
        View in: PubMed
      51. Garcia AA, Yessaian A, Pham H, Facio G, Muderspach L, Roman L. Phase II Study of Gemcitabine and Docetaxel in Recurrent Platinum Resistant Ovarian Cancer. Cancer Invest. 2012 May; 30(4):295-9. PMID: 22468744.
        View in: PubMed
      52. Matsuo K, Prather CP, Ahn EH, Eno ML, Tierney KE, Yessaian AA, Im DD, Rosenshein NB, Roman L. Significance of perioperative infection in survival of patients with ovarian cancer. Int J Gynecol Cancer. 2012 Feb; 22(2):245-53. PMID: 22228425.
        View in: PubMed
      53. Roman L, Kostiuk IP, Shostka KG, Pavlenko AN, Krest'ianinov SS, Vasil'ev LA. [Pelvic exenteration in surgery for colorectal cancer]. Vopr Onkol. 2012; 58(3):363-8. PMID: 22888652.
        View in: PubMed
      54. Matsuo K, Blake EA, Yessaian AA, Roman L. Long-term pegylated liposomal doxorubicin use and oromaxillary squamous cell carcinoma in endometrial cancer. Oncologist. 2012; 17(12):1598-9. PMID: 23263923.
        View in: PubMed
      55. Campan M, Moffitt M, Houshdaran S, Shen H, Widschwendter M, Daxenbichler G, Long T, Marth C, Laird-Offringa IA, Press MF, Dubeau L, Siegmund KD, Wu AH, Groshen S, Chandavarkar U, Roman L, Berchuck A, Pearce CL, Laird PW. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. PLoS One. 2011; 6(12):e28141. PMID: 22163280.
        View in: PubMed
      56. Karachun AM, Sinenchenko GI, Roman L, Samsonov DV, Luft AV, Voshchinin EV. [Characteristics of tumor growth in patients with locally-advanced gastric cancer]. Vopr Onkol. 2011; 57(3):370-2. PMID: 21882610.
        View in: PubMed
      57. Reynolds EA, Tierney K, Keeney GL, Felix JC, Weaver AL, Roman L, Cliby WA. Analysis of outcomes of microinvasive adenocarcinoma of the uterine cervix by treatment type. Obstet Gynecol. 2010 Nov; 116(5):1150-7. PMID: 20966701.
        View in: PubMed
      58. Matsuo K, Lin YG, Roman L, Sood AK. Overcoming platinum resistance in ovarian carcinoma. Expert Opin Investig Drugs. 2010 Nov; 19(11):1339-54. PMID: 20815774.
        View in: PubMed
      59. O'Day SJ, Maio M, Chiarion-Sileni V, Gajewski TF, Pehamberger H, Bondarenko IN, Queirolo P, Lundgren L, Mikhailov S, Roman L, Verschraegen C, Humphrey R, Ibrahim R, de Pril V, Hoos A, Wolchok JD. Efficacy and safety of ipilimumab monotherapy in patients with pretreated advanced melanoma: a multicenter single-arm phase II study. Ann Oncol. 2010 Aug; 21(8):1712-7. PMID: 20147741.
        View in: PubMed
      60. Karachun AM, Sinenchenko GI, Roman L, Samsonov DV, Luft AV. [Outcomes of surgical treatment for locally advanced gastric cancer]. Vopr Onkol. 2010; 56(1):24-8. PMID: 20361611.
        View in: PubMed
      61. Monk BJ, Sill MW, Burger RA, Gray HJ, Buekers TE, Roman L. Phase II trial of bevacizumab in the treatment of persistent or recurrent squamous cell carcinoma of the cervix: a gynecologic oncology group study. J Clin Oncol. 2009 Mar 1; 27(7):1069-74. PMID: 19139430.
        View in: PubMed
      62. Roman L, Kotiv BN, Bisenkov LN, Shostka KG, Kostiuk IP. [Palliative resection in esophageal cancer]. Vopr Onkol. 2009; 55(1):56-9. PMID: 19435201.
        View in: PubMed
      63. Schultheis AM, Lurje G, Rhodes KE, Zhang W, Yang D, Garcia AA, Morgan R, Gandara D, Scudder S, Oza A, Hirte H, Fleming G, Roman L, Lenz HJ. Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab. Clin Cancer Res. 2008 Nov 15; 14(22):7554-63. PMID: 19010874.
        View in: PubMed
      64. Garcia AA, Hirte H, Fleming G, Yang D, Tsao-Wei DD, Roman L, Groshen S, Swenson S, Markland F, Gandara D, Scudder S, Morgan R, Chen H, Lenz HJ, Oza AM. Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia. J Clin Oncol. 2008 Jan 1; 26(1):76-82. PMID: 18165643.
        View in: PubMed
      65. Garcia AA, Blessing JA, Vaccarello L, Roman L. Phase II clinical trial of docetaxel in refractory squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Am J Clin Oncol. 2007 Aug; 30(4):428-31. PMID: 17762444.
        View in: PubMed
      66. Roman L, Wilczynski S, Muderspach LI, Burnett AF, O'Meara A, Brinkman JA, Kast WM, Facio G, Felix JC, Aldana M, Weber JS. A phase II study of Hsp-7 (SGN-00101) in women with high-grade cervical intraepithelial neoplasia. Gynecol Oncol. 2007 Sep; 106(3):558-66. PMID: 17631950.
        View in: PubMed
      67. Brinkman JA, Hughes SH, Stone P, Caffrey AS, Muderspach LI, Roman L, Weber JS, Kast WM. Therapeutic vaccination for HPV induced cervical cancers. Dis Markers. 2007; 23(4):337-52. PMID: 17627067.
        View in: PubMed
      68. Lowe MP, Bahador A, Muderspach LI, Burnett A, Santos L, Caffrey A, Roman L, Morrow CP. Feasibility of laparoscopic extraperitoneal surgical staging for locally advanced cervical carcinoma in a gynecologic oncology fellowship training program. J Minim Invasive Gynecol. 2006 Sep-Oct; 13(5):391-7. PMID: 16962520.
        View in: PubMed
      69. Gordon MS, Matei D, Aghajanian C, Matulonis UA, Brewer M, Fleming GF, Hainsworth JD, Garcia AA, Pegram MD, Schilder RJ, Cohn DE, Roman L, Derynck MK, Ng K, Lyons B, Allison DE, Eberhard DA, Pham TQ, Dere RC, Karlan BY. Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status. J Clin Oncol. 2006 Sep 10; 24(26):4324-32. PMID: 16896006.
        View in: PubMed
      70. Amezcua CA, MacDonald HR, Lum CA, Yi W, Muderspach LI, Roman L, Felix JC. Endometrial cancer patients have a significant risk of harboring isolated tumor cells in histologically negative lymph nodes. Int J Gynecol Cancer. 2006 May-Jun; 16(3):1336-41. PMID: 16803526.
        View in: PubMed
      71. Chernofsky MR, Felix JC, Muderspach LI, Morrow CP, Ye W, Groshen SG, Roman L. Influence of quantity of lymph vascular space invasion on time to recurrence in women with early-stage squamous cancer of the cervix. Gynecol Oncol. 2006 Feb; 100(2):288-93. PMID: 16182347.
        View in: PubMed
      72. Roman L. Pregnancy after radical vaginal trachelectomy: maybe not such a risky undertaking after all. Gynecol Oncol. 2005 Jul; 98(1):1-2. PMID: 15946730.
        View in: PubMed
      73. Mateo R, Singh G, Jabbour N, Palmer S, Genyk Y, Roman L. Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors. Gynecol Oncol. 2005 Apr; 97(1):266-70. PMID: 15790474.
        View in: PubMed
      74. Brinkman JA, Caffrey AS, Muderspach LI, Roman L, Kast WM. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management. Eur J Gynaecol Oncol. 2005; 26(2):129-42. PMID: 15857016.
        View in: PubMed
      75. Garcia AA, Roman L, Muderspach L, O'meara A, Facio G, Edwards S, Burnett A. Phase I clinical trial of topotecan and pegylated liposomal doxorubicin. Cancer Invest. 2005; 23(8):665-70. PMID: 16377584.
        View in: PubMed
      76. Perego C, Roman L, Chase F, Tegtmeier B. Algorithm guides ICP infection investigation. Hosp Case Manag. 2004 Nov; 12(11):167-8. PMID: 15540615.
        View in: PubMed
      77. Burnett AF, O'Meara AT, Bahador A, Roman L, Morrow CP. Extraperitoneal laparoscopic lymph node staging: the University of Southern California experience. Gynecol Oncol. 2004 Oct; 95(1):189-92. PMID: 15385130.
        View in: PubMed
      78. Garcia AA, O'Meara A, Bahador A, Facio G, Jeffers S, Kim DY, Roman L. Phase II study of gemcitabine and weekly paclitaxel in recurrent platinum-resistant ovarian cancer. Gynecol Oncol. 2004 May; 93(2):493-8. PMID: 15099968.
        View in: PubMed
      79. Nouriani M, Bahador A, Berek JS, Cheng JP, Chi DS, Cliby WA, Del Priore G, Dodson MK, Duggan BD, Gershenson DM, Lentz SE, Penson RT, Robinson WR, Rodriguez M, Roman L, Yu MC, Zempolich K, Dubeau L. Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy. Clin Cancer Res. 2004 Apr 15; 10(8):2681-6. PMID: 15102671.
        View in: PubMed
      80. Roman L, Fedorov KA, Krasnozhon DA. [Comparative clinical evaluation of the effectiveness of modified radical mastectomy and organ-preserving therapy in localized breast cancer (pT1-2N0M0)]. Vopr Onkol. 2004; 50(1):99-100. PMID: 15088531.
        View in: PubMed
      81. Burnett AF, Roman L, O'Meara AT, Morrow CP. Radical vaginal trachelectomy and pelvic lymphadenectomy for preservation of fertility in early cervical carcinoma. Gynecol Oncol. 2003 Mar; 88(3):419-23. PMID: 12648596.
        View in: PubMed
      82. Safra T, Groshen S, Jeffers S, Tsao-Wei DD, Zhou L, Muderspach L, Roman L, Morrow CP, Burnett A, Muggia FM. Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome. Cancer. 2001 Jan 1; 91(1):90-100. PMID: 11148564.
        View in: PubMed
      83. Burnett AF, Coe FL, Klement V, O'Meara AT, Muderspach LI, Roman L, Morrow CP. The use of a pelvic displacement prosthesis to exclude the small intestine from the radiation field following radical hysterectomy. Gynecol Oncol. 2000 Dec; 79(3):438-43. PMID: 11104616.
        View in: PubMed
      84. Muderspach L, Wilczynski S, Roman L, Bade L, Felix J, Small LA, Kast WM, Fascio G, Marty V, Weber J. A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV 16 positive. Clin Cancer Res. 2000 Sep; 6(9):3406-16. PMID: 10999722.
        View in: PubMed
      85. Israel VP, Garcia AA, Roman L, Muderspach L, Burnett A, Jeffers S, Muggia FM. Phase II study of liposomal doxorubicin in advanced gynecologic cancers. Gynecol Oncol. 2000 Aug; 78(2):143-7. PMID: 10926793.
        View in: PubMed
      86. Liaw YF, Leung NW, Chang TT, Guan R, Tai DI, Ng KY, Chien RN, Dent J, Roman L, Edmundson S, Lai CL. Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B. Asia Hepatitis Lamivudine Study Group. Gastroenterology. 2000 Jul; 119(1):172-80. PMID: 10889166.
        View in: PubMed
      87. Stoiko IuM, Roman L, Karachun AM. [Ulcerated forms of gastric cancer as a clinical problem]. Vestn Khir Im I I Grek. 2000; 159(5):110-3. PMID: 11188807.
        View in: PubMed
      88. Miroshnikov BI, Pavelets KV, Marochkin NE, Roman L, Shostka KG, Shiriaev IuN. [Long-term outcome of surgical treatment of patients with esophageal cancer]. Vestn Khir Im I I Grek. 2000; 159(4):33-6. PMID: 11011399.
        View in: PubMed
      89. Burnett AF, Roman L, Garcia AA, Muderspach LI, Brader KR, Morrow CP. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix. Gynecol Oncol. 2000 Jan; 76(1):63-6. PMID: 10620443.
        View in: PubMed
      90. Duggan BD, Felix JC, Muderspach LI, Gebhardt JA, Groshen S, Morrow CP, Roman L. Cold-knife conization versus conization by the loop electrosurgical excision procedure: a randomized, prospective study. Am J Obstet Gynecol. 1999 Feb; 180(2 Pt 1):276-82. PMID: 9988787.
        View in: PubMed
      91. Miroshnikov BI, Roman L, Pavelets KV, Shostka KG, Burakov VV. [Lymph node dissection in esophageal cancer]. Vestn Khir Im I I Grek. 1999; 158(5):50-3. PMID: 10645582.
        View in: PubMed
      92. Look KY, Blessing JA, Levenback C, Kohler M, Chafe W, Roman L. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study. Gynecol Oncol. 1998 Sep; 70(3):334-8. PMID: 9790784.
        View in: PubMed
      93. Roman L, Muderspach LI, Burnett AF, Morrow CP. Carcinoembryonic antigen in women with isolated pelvic masses. Clinical utility? J Reprod Med. 1998 May; 43(5):403-7. PMID: 9610461.
        View in: PubMed
      94. Roman L. Small cystic pelvic masses in older women: is surgical removal necessary? Gynecol Oncol. 1998 Apr; 69(1):1-2. PMID: 9570989.
        View in: PubMed
      95. Roman L, Felix JC, Muderspach LI, Varkey T, Burnett AF, Qian D, Morrow CP. Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix. Gynecol Oncol. 1998 Mar; 68(3):220-5. PMID: 9570969.
        View in: PubMed
      96. Duggan BD, Wan M, Yu MC, Roman L, Muderspach LI, Delgadillo E, Li WZ, Martin SE, Dubeau L. Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination. J Natl Cancer Inst. 1998 Feb 4; 90(3):238-42. PMID: 9462682.
        View in: PubMed
      97. Roman L, Felix JC, Muderspach LI, Agahjanian A, Qian D, Morrow CP. Risk of residual invasive disease in women with microinvasive squamous cancer in a conization specimen. Obstet Gynecol. 1997 Nov; 90(5):759-64. PMID: 9351760.
        View in: PubMed
      98. Muggia FM, Jeffers S, Muderspach L, Roman L, Rosales R, Groshen S, Safra T, Morrow CP. Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin). Gynecol Oncol. 1997 Aug; 66(2):290-4. PMID: 9264578.
        View in: PubMed
      99. Muderspach LI, Curtin JP, Roman L, Gebhardt JA, Klement V, Qian D, Morrow CP, Felix JC, Formenti SC, Muggia FM. Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study. Gynecol Oncol. 1997 May; 65(2):336-42. PMID: 9159348.
        View in: PubMed
      100. Roman L, Muderspach LI, Stein SM, Laifer-Narin S, Groshen S, Morrow CP. Pelvic examination, tumor marker level, and gray-scale and Doppler sonography in the prediction of pelvic cancer. Obstet Gynecol. 1997 Apr; 89(4):493-500. PMID: 9083301.
        View in: PubMed
      101. Muggia FM, Hainsworth JD, Jeffers S, Miller P, Groshen S, Tan M, Roman L, Uziely B, Muderspach L, Garcia A, Burnett A, Greco FA, Morrow CP, Paradiso LJ, Liang LJ. Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol. 1997 Mar; 15(3):987-93. PMID: 9060537.
        View in: PubMed
      102. Roman L, Bogorodskii IP, Skriabin ON, Fedorov KA, Naumov EV. [Successful surgical treatment of cancer with multiple location]. Vopr Onkol. 1997; 43(2):230. PMID: 9214133.
        View in: PubMed
      103. Moyses HM, Morrow CP, Muderspach LI, Roman L, Vasilev SA, Petrovich Z, Groshen SL, Klement V. Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage IB cervical carcinoma. Am J Clin Oncol. 1996 Oct; 19(5):433-8. PMID: 8823468.
        View in: PubMed
      104. Shurkus VE, Roman L, Shurkus EA. [Variants in the definitive organization of the lumbar lymph-conducting pathways in the applied aspect]. Vestn Khir Im I I Grek. 1996; 155(6):49-53. PMID: 9163155.
        View in: PubMed
      105. Barnhill DR, Kurman RJ, Brady MF, Omura GA, Yordan E, Given FT, Kucera PR, Roman L. Preliminary analysis of the behavior of stage I ovarian serous tumors of low malignant potential: a Gynecologic Oncology Group study. J Clin Oncol. 1995 Nov; 13(11):2752-6. PMID: 7595734.
        View in: PubMed
      106. Stein SM, Laifer-Narin S, Johnson MB, Roman L, Muderspach LI, Tyszka JM, Ralls PW. Differentiation of benign and malignant adnexal masses: relative value of gray-scale, color Doppler, and spectral Doppler sonography. AJR Am J Roentgenol. 1995 Feb; 164(2):381-6. PMID: 7839975.
        View in: PubMed
      107. Kobak WH, Roman L, Felix JC, Muderspach LI, Schlaerth JB, Morrow CP. The role of endocervical curettage at cervical conization for high-grade dysplasia. Obstet Gynecol. 1995 Feb; 85(2):197-201. PMID: 7824230.
        View in: PubMed
      108. Israel VK, Jiang C, Muggia FM, Tulpule A, Jeffers S, Leichman L, Morrow CP, Roman L, Leichman CG, Chan KK. Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study. Cancer Chemother Pharmacol. 1995; 37(1-2):32-8. PMID: 7497594.
        View in: PubMed
      109. Felix JC, Muderspach LI, Duggan BD, Roman L. The significance of positive margins in loop electrosurgical cone biopsies. Obstet Gynecol. 1994 Dec; 84(6):996-1000. PMID: 7970484.
        View in: PubMed
      110. Uziely B, Groshen S, Jeffers S, Morris M, Russell C, Roman L, Muderspach L, Muggia F. Paclitaxel (Taxol) in heavily pretreated ovarian cancer: antitumor activity and complications. Ann Oncol. 1994 Nov; 5(9):827-33. PMID: 7848885.
        View in: PubMed
      111. Zweizig S, Roman L, Muderspach LI. Death from anaphylaxis to cisplatin: a case report. Gynecol Oncol. 1994 Apr; 53(1):121-2. PMID: 8175010.
        View in: PubMed
      112. Duggan B, Muderspach LI, Roman L, Curtin JP, d'Ablaing G, Morrow CP. Cervical cancer in pregnancy: reporting on planned delay in therapy. Obstet Gynecol. 1993 Oct; 82(4 Pt 1):598-602. PMID: 8377988.
        View in: PubMed
      113. Roman L, Morris M, Mitchell MF, Eifel PJ, Burke TW, Atkinson EN. Prognostic factors for patients undergoing simple hysterectomy in the presence of invasive cancer of the cervix. Gynecol Oncol. 1993 Aug; 50(2):179-84. PMID: 8375732.
        View in: PubMed
      114. Roman L, Mitchell MF, Tornos C, Glover A, Kavanagh JJ. Dedifferentiated extrauterine adenosarcoma responsive to chemotherapy. Gynecol Oncol. 1993 Jun; 49(3):389-94. PMID: 8390963.
        View in: PubMed
      115. Roman L, Morris M, Eifel PJ, Burke TW, Gershenson DM, Wharton JT. Reasons for inappropriate simple hysterectomy in the presence of invasive cancer of the cervix. Obstet Gynecol. 1992 Apr; 79(4):485-9. PMID: 1553163.
        View in: PubMed
      116. Hunter RE, Griffin TW, Stevens S, Roman L, Bokhari F, Reale FR, Tak WK, Fitzgerald TJ, Dillon MB, Rose PG. High-dose, short-duration cisplatin/doxorubicin combination chemotherapy for advanced ovarian epithelial cancer. Cancer. 1991 Nov 1; 68(9):1890-4. PMID: 1655227.
        View in: PubMed
      117. Roman L, Mitchell MF, Burke TW, Silva EG. Unsuspected invasive squamous cell carcinoma of the vulva in young women. Gynecol Oncol. 1991 May; 41(2):182-5. PMID: 2050311.
        View in: PubMed
      118. Rose PG, Roman L, Reale FR, Tak WK, Hunter RE. Primary adenocarcinoma of the breast arising in the vulva. Obstet Gynecol. 1990 Sep; 76(3 Pt 2):537-9. PMID: 2199874.
        View in: PubMed